Connection

Cheng-Feng Qin to Humans

This is a "connection" page, showing publications Cheng-Feng Qin has written about Humans.
Connection Strength

0.129
  1. Generation and Characterization of a Nanobody Against SARS-CoV. Virol Sin. 2021 Dec; 36(6):1484-1491.
    View in: PubMed
    Score: 0.008
  2. Convergent evolution of SARS-CoV-2 in human and animals. Protein Cell. 2021 11; 12(11):832-835.
    View in: PubMed
    Score: 0.008
  3. Longitudinal dynamics of antibody responses in recovered COVID-19 patients. Signal Transduct Target Ther. 2021 03 31; 6(1):137.
    View in: PubMed
    Score: 0.008
  4. The m6A methylome of SARS-CoV-2 in host cells. Cell Res. 2021 04; 31(4):404-414.
    View in: PubMed
    Score: 0.007
  5. 25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor. Cell Res. 2020 11; 30(11):1043-1045.
    View in: PubMed
    Score: 0.007
  6. A Thermostable mRNA Vaccine against COVID-19. Cell. 2020 09 03; 182(5):1271-1283.e16.
    View in: PubMed
    Score: 0.007
  7. Old Master Zhu: in memory of virologist Guan-Fu Zhu. Protein Cell. 2018 09; 9(9):749-751.
    View in: PubMed
    Score: 0.006
  8. Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone. Nat Commun. 2018 02 14; 9(1):673.
    View in: PubMed
    Score: 0.006
  9. A single residue in the aB helix of the E protein is critical for Zika virus thermostability. Emerg Microbes Infect. 2018 01 24; 7(1):5.
    View in: PubMed
    Score: 0.006
  10. Intranasal infection and contact transmission of Zika virus in guinea pigs. Nat Commun. 2017 11 21; 8(1):1648.
    View in: PubMed
    Score: 0.006
  11. A single mutation in the prM protein of Zika virus contributes to fetal microcephaly. Science. 2017 11 17; 358(6365):933-936.
    View in: PubMed
    Score: 0.006
  12. Immunization with truncated envelope protein of Zika virus induces protective immune response in mice. Sci Rep. 2017 08 30; 7(1):10047.
    View in: PubMed
    Score: 0.006
  13. Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines. Cell Res. 2021 07; 31(7):732-741.
    View in: PubMed
    Score: 0.002
  14. Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients. Front Immunol. 2021; 12:603563.
    View in: PubMed
    Score: 0.002
  15. Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays. Emerg Microbes Infect. 2020 Dec; 9(1):2269-2277.
    View in: PubMed
    Score: 0.002
  16. Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protection. Cell Res. 2021 01; 31(1):25-36.
    View in: PubMed
    Score: 0.002
  17. Structure-based development of human antibody cocktails against SARS-CoV-2. Cell Res. 2021 01; 31(1):101-103.
    View in: PubMed
    Score: 0.002
  18. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Nat Metab. 2020 12; 2(12):1391-1400.
    View in: PubMed
    Score: 0.002
  19. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy. Science. 2020 09 25; 369(6511):1603-1607.
    View in: PubMed
    Score: 0.002
  20. Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody. Science. 2020 09 18; 369(6510):1505-1509.
    View in: PubMed
    Score: 0.002
  21. Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19. J Allergy Clin Immunol Pract. 2020 09; 8(8):2585-2591.e1.
    View in: PubMed
    Score: 0.002
  22. Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells. Cell. 2020 07 09; 182(1):73-84.e16.
    View in: PubMed
    Score: 0.002
  23. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals. Immunity. 2020 06 16; 52(6):971-977.e3.
    View in: PubMed
    Score: 0.002
  24. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020 06; 582(7811):289-293.
    View in: PubMed
    Score: 0.002
  25. Infectivity of Zika virus on primary cells support tree shrew as animal model. Emerg Microbes Infect. 2019; 8(1):232-241.
    View in: PubMed
    Score: 0.002
  26. Integrative Analysis of Zika Virus Genome RNA Structure Reveals Critical Determinants of Viral Infectivity. Cell Host Microbe. 2018 12 12; 24(6):875-886.e5.
    View in: PubMed
    Score: 0.002
  27. Differential antiviral immunity to Japanese encephalitis virus in developing cortical organoids. Cell Death Dis. 2018 06 18; 9(7):719.
    View in: PubMed
    Score: 0.002
  28. Salivary factor LTRIN from Aedes aegypti facilitates the transmission of Zika virus by interfering with the lymphotoxin-ß receptor. Nat Immunol. 2018 04; 19(4):342-353.
    View in: PubMed
    Score: 0.002
  29. Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants. PLoS One. 2018; 13(1):e0189262.
    View in: PubMed
    Score: 0.001
  30. Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease. Antiviral Res. 2018 02; 150:217-225.
    View in: PubMed
    Score: 0.001
  31. American Strain of Zika Virus Causes More Severe Microcephaly Than an Old Asian Strain in Neonatal Mice. EBioMedicine. 2017 Nov; 25:95-105.
    View in: PubMed
    Score: 0.001
  32. Phylogenetic and genetic characterization of a 2017 clinical isolate of H7N9 virus in Guangzhou, China during the fifth epidemic wave. Sci China Life Sci. 2017 12; 60(12):1331-1339.
    View in: PubMed
    Score: 0.001
  33. The importation of the phylogenetic-transition state of Zika virus to China in 2014. J Infect. 2018 01; 76(1):106-109.
    View in: PubMed
    Score: 0.001
  34. Zika-Virus-Encoded NS2A Disrupts Mammalian Cortical Neurogenesis by Degrading Adherens Junction Proteins. Cell Stem Cell. 2017 09 07; 21(3):349-358.e6.
    View in: PubMed
    Score: 0.001
  35. Zika virus directly infects peripheral neurons and induces cell death. Nat Neurosci. 2017 Sep; 20(9):1209-1212.
    View in: PubMed
    Score: 0.001
  36. A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses. Nat Commun. 2017 07 25; 8:15672.
    View in: PubMed
    Score: 0.001
  37. Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction. Cell Res. 2017 Aug; 27(8):1046-1064.
    View in: PubMed
    Score: 0.001
  38. Human Virus-Derived Small RNAs Can Confer Antiviral Immunity in Mammals. Immunity. 2017 06 20; 46(6):992-1004.e5.
    View in: PubMed
    Score: 0.001
  39. Vector competence and transovarial transmission of two Aedes aegypti strains to Zika virus. Emerg Microbes Infect. 2017 Apr 26; 6(4):e23.
    View in: PubMed
    Score: 0.001
  40. 25-Hydroxycholesterol Protects Host against Zika Virus Infection and Its Associated Microcephaly in a Mouse Model. Immunity. 2017 03 21; 46(3):446-456.
    View in: PubMed
    Score: 0.001
  41. Generation and characterization of West Nile pseudo-infectious reporter virus for antiviral screening. Antiviral Res. 2017 05; 141:38-47.
    View in: PubMed
    Score: 0.001
  42. U4 at the 3' UTR of PB1 segment of H5N1 influenza virus promotes RNA polymerase activity and contributes to viral pathogenicity. PLoS One. 2014; 9(3):e93366.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.